Compare Novavax Inc (NVAX) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Stryker Corporation — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Stryker Corporation trades at $314.62 (market cap $122.35B). The key difference: Stryker Corporation is far larger — about 94.1× Novavax Inc's market cap, and Stryker Corporation pays a 1% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | SYK | |
|---|---|---|
Market Cap | $1.30B | $122.35B |
Sector | Health | Technology |
52-Week High | $11.19 | $403.53 |
52-Week Low | $6.22 | $282.58 |
Enterprise Value | $800.50M | $134.10B |
Dividend Yield | — | 1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
